neurology Archives -

Biogen and Eisai have resurrected hopes that amyloid-targeting drugs could have a benefit in Alzheimer’s disease with a

Biogen, Eisai say lecanemab has aced phase 3 Alzheimer’s study

https://pharmaphorum.com/news/biogen-eisai-say-lecanemab-has-aced-phase-3-alzheimers-study/

Biogen trumpets data from ALS trial as FDA decision looms

Phil Taylor amyotrophic lateral sclerosis, antisense drugs, Biogen, motor neurone disease, neurology, rare disease, tofersen 0 Comment

After a torrid couple of years, Biogen can be forgiven for making the most of new data on

Biogen trumpets data from ALS trial as FDA decision looms

https://pharmaphorum.com/news/biogen-trumpets-data-from-als-trial-as-fda-decision-looms/

jason-rosewell-voice-microphone-child-unsplash

Digital/ News/ News/ News/ R&D

Could cancer be diagnosed from the sound of a voice?

Phil Taylor cancer, diagnostic, digital, digital health, neurology, Owkin, Psychiatry, vocal biomarkers 0 Comment

A $14 million research project is getting underway in the US to see whether cancer and other diseases

Could cancer be diagnosed from the sound of a voice?

https://pharmaphorum.com/news/could-cancer-be-diagnosed-from-the-sound-of-a-voice/

Digital/ News/ News

Cumulus’ gamified dry EEG system tops lab monitoring in trial

Phil Taylor Cumulus Neuroscience, dementia, digital, digital biomarker, digital health, neurology 0 Comment

An at-home electroencephalogram (EEG) headset used alongside game-like cognitive tasks developed by UK company Cumulus Neuroscience has been

Cumulus’ gamified dry EEG system tops lab monitoring in trial

https://pharmaphorum.com/news/cumulus-gamified-dry-eeg-system-tops-lab-monitoring-in-trial/

News/ News/ R&D

Merck swings back into Alzheimer’s with $1.1bn Cerevance alliance

Phil Taylor Alzheimer's disease, Cerevance, licensing, Merck & Co, neurology, partnering 0 Comment

Merck & Co’s earlier efforts to find new therapies for Alzheimer’s disease resulted in failure, but the company

Merck swings back into Alzheimer’s with $1.1bn Cerevance alliance

https://pharmaphorum.com/news/merck-swings-back-into-alzheimers-with-1-1bn-cerevance-alliance/

Digital/ News/ News/ News/ Patients

Koneksa aims to answer Parkinson’s-tracking challenge with AI

Phil Taylor digital, digital biomarker, digital health, Koneksa, neurology, Parkinson's disease, Verily, wearable 0 Comment

Healthcare technology firm Koneksa will carry out a study to evaluate whether digital biomarkers can be used to

Koneksa aims to answer Parkinson’s-tracking challenge with AI

https://pharmaphorum.com/news/koneksa-aims-to-answer-parkinsons-tracking-challenge-with-ai/

News/ News/ R&D

AbbVie taps Sosei Heptares GPCR expertise with $1.2bn+ alliance

Phil Taylor AbbVie, GPCR, neurology, partnering, Sosei Heptares 0 Comment

Sosei Heptares has signed up a string of big pharma collaborators over the last few years, and one

AbbVie taps Sosei Heptares GPCR expertise with $1.2bn+ alliance

https://pharmaphorum.com/news/abbvie-taps-sosei-heptares-gpcr-expertise-with-1-2bn-alliance/

Market Access/ News/ News

Biogen gets much-needed pipeline lift with speedy ALS drug review

Phil Taylor amyotrophic lateral sclerosis, antisense oligonucleotides, Biogen, neurology, regulatory, tofersen 0 Comment

Beleaguered Biogen has been handed some encouraging news from the FDA, after the regulator agreed to complete its

Biogen gets much-needed pipeline lift with speedy ALS drug review

https://pharmaphorum.com/news/biogen-gets-much-needed-pipeline-lift-with-speedy-als-drug-review/

Close Up Of Senior Man Suffering With Parkinsons Diesease

News/ News/ R&D

Kyowa Kirin drops Nourianz follow-up KW-6356 for Parkinson’s

Phil Taylor KW-6356, Kyowa Kirin, neurology, Nourianz, Parkinson's disease 0 Comment

Despite reporting proof-of-concept results in a mid-stage trial, Kyowa Kirin has decided to discontinue development of its Parkinson’s

Kyowa Kirin drops Nourianz follow-up KW-6356 for Parkinson’s

https://pharmaphorum.com/news/kyowa-kirin-drops-nourianz-follow-up-kw-6356-for-parkinsons/

Trending

neurology

Login